Transcranial Direct Current Stimulation for Chronic Pain Relief
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
tDCS is a noninvasive brain stimulation technique that utilizes low amplitude direct currents applied via scalp electrodes to modulate the level of cortical excitability.Several studies have demonstrated that tDCS applied over the sensory-motor cortex has been able to decrease pain sensation and to increase pain threshold in healthy subjects and in chronic pain patients.
The aim of this study was to test whether daily sessions of anodal tDCS repeated for 5 consecutive days may be effective in reducing pain in a large number of chronic pain patients.
Patients will receive sham tDCS or real tDCS in a 5-day period of treatment in a randomized, sham controlled study. The participants will be divided to 2 groups of 50 each. One group will receive 5 days period of 20 min 2mA tDCS over the lt M1 and the other will receive sham stimulation. X week later the groups will switch to the other arm.
Pain will be measured using visual analog scale (VAS) for pain and the short form McGill questionnaire (SF-MPQ). Disability will be measured using the ( Pain Disability Index (PDI) of Life-54 scale (MSQoL-54). Depressive symptoms and anxiety will also be evaluated using the Center for Epidemiological Studies-Depression Scale and the State-trait Anxiety Inventory (STAI). Cognitive function will be mesured using minimental test. Evaluations will be performed at baseline, immediately after the end of treatment, and once a week during a 3-week follow-up period.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- over 18
- chronic pain patients VAS > 4
Exclusion Criteria:
- pregnancy
- scalp lacerations
- History of seizures
- metal implants in the head
- heart pace maker
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: direct current stimulation
The participants will be divided to 2 groups of 50 each.
One group will receive 5 days period of 20 min 2mA tDCS over the lt M1 and the other will receive sham stimulation.
X week later the groups will switch to the other arm.
|
Patients will receive sham tDCS or real tDCS in a 5-day period of treatment in a randomized, sham controlled study.
The participants will be divided to 2 groups of 50 each.
One group will receive 5 days period of 20 min 2mA tDCS over the lt M1 and the other will receive sham stimulation.
X week later the groups will switch to the other arm
|
|
Comparateur factice: simulation de stimulation
|
Patients will receive sham tDCS or real tDCS in a 5-day period of treatment in a randomized, sham controlled study.
The participants will be divided to 2 groups of 50 each.
One group will receive 5 days period of 20 min 2mA tDCS over the lt M1 and the other will receive sham stimulation.
X week later the groups will switch to the other arm
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Soulagement de la douleur
Délai: 5 jours
|
5 jours
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Avaluation of tDCS treatment for chronic pain on disability, depression, anxiety, and cognition of treated patients.
Délai: 5 days
|
5 days
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- TASMC-10-SB-396-CTIL
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .